Tang L et al. |
Effects of different magnitudes of mechanical strain on Osteoblasts in vitro. |
2006 |
Biochem. Biophys. Res. Commun. |
pmid:16603128
|
Nakashima A et al. |
Osteoprotegerin and bone mineral density in hemodialysis patients. |
2006 |
Osteoporos Int |
pmid:16604298
|
Vis M et al. |
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. |
2006 |
Ann. Rheum. Dis. |
pmid:16606653
|
Villa I et al. |
CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. |
2006 |
Am. J. Physiol., Cell Physiol. |
pmid:16611736
|
Barreto FC et al. |
Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. |
2006 |
Kidney Int. |
pmid:16612334
|
Swanson C et al. |
Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. |
2006 |
Endocrinology |
pmid:16614077
|
Demer LL and Tintut Y |
Pitting phosphate transport inhibitors against vascular calcification. |
2006 |
Circ. Res. |
pmid:16614308
|
Vik A et al. |
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. |
2007 |
Atherosclerosis |
pmid:16620835
|
Wang Q et al. |
[Effect of estrogen on osteoprotegerin, osteoclast differentiation factor and macrophage colony stimulating factor mRNA expressions in ovariectomized rat bone tissue]. |
2006 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:16624776
|
Dynybil C et al. |
[The effect of osteoprotegerin on tendon-bone healing after reconstruction of the anterior cruciate ligament: a histomorphological and radiographical study in the rabbit]. |
2006 Mar-Apr |
Z Orthop Ihre Grenzgeb |
pmid:16625448
|
Yamamoto Y et al. |
Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand. |
2006 |
Endocrinology |
pmid:16627581
|
Kanzaki H et al. |
Cyclical tensile force on periodontal ligament cells inhibits osteoclastogenesis through OPG induction. |
2006 |
J. Dent. Res. |
pmid:16632761
|
Bersinger NA et al. |
PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. |
2006 |
Am. J. Obstet. Gynecol. |
pmid:16635455
|
Wang GF et al. |
Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. |
2006 |
Pharmacology |
pmid:16636611
|
Yang M et al. |
The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model. |
2006 |
Clin. Cancer Res. |
pmid:16638872
|
Hofbauer LC |
Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG). |
2006 |
Ann. Endocrinol. (Paris) |
pmid:16639364
|
Matemba SF et al. |
Regulation of osteoclastogenesis by gap junction communication. |
2006 |
J. Cell. Biochem. |
pmid:16639710
|
Lau YS et al. |
Malignant melanoma and bone resorption. |
2006 |
Br. J. Cancer |
pmid:16641914
|
Makrygiannakis D et al. |
Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. |
2006 |
Arthritis Rheum. |
pmid:16646024
|
Sylvester FA et al. |
Are activated T cells regulators of bone metabolism in children with Crohn disease? |
2006 |
J. Pediatr. |
pmid:16647405
|
Coetzee M et al. |
Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells. |
2007 |
J. Nutr. Biochem. |
pmid:16650751
|
Li Y et al. |
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. |
2006 |
Cancer Res. |
pmid:16651437
|
Takayanagi K et al. |
Effects of enamel matrix derivative on bone-related mRNA expression in human periodontal ligament cells in vitro. |
2006 |
J. Periodontol. |
pmid:16671883
|
Vik A et al. |
Serum osteoprotegerin in young survivors of myocardial infarction. |
2006 |
Thromb. Haemost. |
pmid:16676081
|
Zhong N et al. |
[Relationship between polymorphism of parathyroid hormone and bone mineral density and relevant biochemical indicators in women]. |
2006 |
Zhonghua Yi Xue Za Zhi |
pmid:16677544
|
Ohmori R et al. |
Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men. |
2006 |
Atherosclerosis |
pmid:16678184
|
Aoki K et al. |
A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. |
2006 |
J. Clin. Invest. |
pmid:16680194
|
Anand DV et al. |
The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. |
2006 |
J. Am. Coll. Cardiol. |
pmid:16682312
|
Mesquita M et al. |
Bone cytokines and renal osteodystrophy in peritoneal dialysis patients. |
2005 |
Adv Perit Dial |
pmid:16686314
|
Grzegorzewska AE and Mlot M |
Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients. |
2005 |
Adv Perit Dial |
pmid:16686316
|
Hjelmesaeth J et al. |
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. |
2006 |
J. Am. Soc. Nephrol. |
pmid:16687626
|
Chaki O |
[Osteoporosis]. |
2006 |
Nippon Rinsho |
pmid:16689336
|
Hess U |
[The plasma cell myeloma--molecular pathogenesis and target therapies]. |
2006 |
Ther Umsch |
pmid:16689452
|
Burton A |
Regulation of RANKL might reduce bone metastases . |
2006 |
Lancet Oncol. |
pmid:16696160
|
Wang Q et al. |
[Effects of soybean isoflavones on expression levels of osteoprotegerin and osteoprotegerin ligand mRNAs in bone tissues of ovariectomized rats]. |
2006 |
Zhong Xi Yi Jie He Xue Bao |
pmid:16696921
|
Liu YH et al. |
[Effects of kangfengshi granules on expressions of osteoprotegerin, RANKL and M-CSF in bone tissues of rats with collagen-induced arthritis]. |
2006 |
Zhong Xi Yi Jie He Xue Bao |
pmid:16696922
|
Gannagé-Yared MH et al. |
Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. |
2006 |
Clin. Endocrinol. (Oxf) |
pmid:16712667
|
Rhee EJ et al. |
The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans. |
2006 |
Clin. Endocrinol. (Oxf) |
pmid:16712673
|
Tannehill-Gregg SH et al. |
The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. |
2006 |
Clin. Exp. Metastasis |
pmid:16715352
|
Thommesen L et al. |
Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. |
2006 |
J. Cell. Biochem. |
pmid:16721825
|
Liu YH et al. |
[Effect of Herba Epimedii flavone on the osteoblasts metabolism in vitro]. |
2006 |
Zhongguo Zhong Yao Za Zhi |
pmid:16722381
|
Gori F et al. |
Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development. |
2006 |
Dev. Biol. |
pmid:16730692
|
Geusens PP et al. |
The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. |
2006 |
Arthritis Rheum. |
pmid:16736519
|
Shin HH et al. |
Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. |
2006 |
Bone |
pmid:16750437
|
Zauli G and Secchiero P |
The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. |
2006 |
Cytokine Growth Factor Rev. |
pmid:16750931
|
Tat SK et al. |
OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation. |
2006 |
Bone |
pmid:16750945
|
Sasaki N and Kusano E |
[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement and clinical role of OPG]. |
2006 |
Clin Calcium |
pmid:16751691
|
Chen G et al. |
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. |
2006 |
Cancer |
pmid:16752412
|
Samadfam R et al. |
Implication of prostaglandin receptors in the accumulation of osteoprotegerin in human osteoblast cultures. |
2006 |
J. Rheumatol. |
pmid:16755666
|
Nishijima Y et al. |
Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. |
2006 |
Orthod Craniofac Res |
pmid:16764680
|
Chen WF and Wong MS |
Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells. |
2006 |
Br. J. Nutr. |
pmid:16768824
|
Nagae M et al. |
Osteoclasts play a part in pain due to the inflammation adjacent to bone. |
2006 |
Bone |
pmid:16769263
|
Pérez-MartÃnez FC et al. |
Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand. |
2007 |
J. Clin. Pathol. |
pmid:16775117
|
Kacena MA et al. |
Megakaryocyte-mediated inhibition of osteoclast development. |
2006 |
Bone |
pmid:16782418
|
Messalli EM et al. |
Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women. |
2007 |
Maturitas |
pmid:16787719
|
Wakita T et al. |
Increase in RANKL: OPG ratio in synovia of patients with temporomandibular joint disorder. |
2006 |
J. Dent. Res. |
pmid:16798863
|
Shin JY et al. |
Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes. |
2006 |
Diabetes Care |
pmid:16801598
|
Xiang GD et al. |
The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. |
2006 |
Diabetes |
pmid:16804084
|
Galli C et al. |
Osteoprotegerin and receptor activator of nuclear factor-kappa B ligand modulation by enamel matrix derivative in human alveolar osteoblasts. |
2006 |
J. Periodontol. |
pmid:16805686
|
Holding CA et al. |
The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. |
2006 |
Biomaterials |
pmid:16806459
|
Kazama JJ et al. |
Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism. |
2006 |
Ther Apher Dial |
pmid:16817791
|
Granchi D et al. |
Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. |
2006 |
J Bone Joint Surg Am |
pmid:16818976
|
Lee KS et al. |
An antioxidant modulates expression of receptor activator of NF-kappaB in asthma. |
2006 |
Exp. Mol. Med. |
pmid:16819280
|
Schenk-Braat EA and Bangma CH |
[The search for better markers for prostate cancer than prostate-specific antigen]. |
2006 |
Ned Tijdschr Geneeskd |
pmid:16821452
|
Fiore CE et al. |
Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. |
2006 |
Horm. Metab. Res. |
pmid:16823725
|
Fábrega E et al. |
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation. |
2006 May-Jun |
Clin Transplant |
pmid:16824158
|
Jeong JH et al. |
Expression of RANKL and OPG in middle ear cholesteatoma tissue. |
2006 |
Laryngoscope |
pmid:16826057
|
Chung YH et al. |
Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. |
2006 |
J. Periodont. Res. |
pmid:16827722
|
Lu HK et al. |
Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. |
2006 |
J. Periodont. Res. |
pmid:16827732
|
Théoleyre S et al. |
Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. |
2006 |
Biochem. Biophys. Res. Commun. |
pmid:16828054
|
Valero C et al. |
Osteoprotegerin and bone mass in squamous cell head and neck cancer patients. |
2006 |
Calcif. Tissue Int. |
pmid:16830204
|
Glass DA and Karsenty G |
Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:16831912
|
Whyte MP |
Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:16831914
|
Zallone A |
Direct and indirect estrogen actions on osteoblasts and osteoclasts. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:16831916
|
Liu XH et al. |
Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:16831922
|
Matsumoto T and Abe M |
Bone destruction in multiple myeloma. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:16831932
|
Brunetti G et al. |
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:16831934
|
Bennett BJ et al. |
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. |
2006 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16840715
|
Pepe J et al. |
Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. |
2006 |
Br. J. Haematol. |
pmid:16848794
|
Kim CH et al. |
Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling. |
2006 |
Bone |
pmid:16860618
|
Nemoto E et al. |
Regulation of cementoblast function by P. gingivalis lipopolysaccharide via TLR2. |
2006 |
J. Dent. Res. |
pmid:16861291
|
Yamaguchi M et al. |
RANKL increase in compressed periodontal ligament cells from root resorption. |
2006 |
J. Dent. Res. |
pmid:16861294
|
Grzegorzewska AE and MÅ‚ot M |
Serum markers of bone turnover in dialyzed patients separated according to age. |
2006 |
Int Urol Nephrol |
pmid:16868703
|
Robertson KM et al. |
Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. |
2006 |
J. Bone Miner. Res. |
pmid:16869726
|
Kastritis E et al. |
Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support. |
2006 |
Clin Lymphoma Myeloma |
pmid:16879774
|
Schwarz C et al. |
Diagnosis of renal osteodystrophy. |
2006 |
Eur. J. Clin. Invest. |
pmid:16884394
|
Michou L et al. |
[Molecular analysis of Paget's disease of bone]. |
2007 Apr-May |
Pathol. Biol. |
pmid:16884862
|
Karosi T et al. |
Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity. |
2006 |
Laryngoscope |
pmid:16885748
|
Franklin M et al. |
Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. |
2006 |
Bone |
pmid:16890505
|
Mikosch P et al. |
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer. |
2006 |
Eur. J. Clin. Invest. |
pmid:16893379
|
Ziółkowska H and Roszkowska-Blaim M |
[Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure]. |
2006 |
Prz. Lek. |
pmid:16898492
|
Baek KH et al. |
Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism. |
2006 |
Bone |
pmid:16905375
|
Bernstein CN |
Inflammatory bowel diseases as secondary causes of osteoporosis. |
2006 |
Curr Osteoporos Rep |
pmid:16908001
|
Mochizuki Y et al. |
Correlation between serum osteoprotegerin and biomarkers of bone metabolism during anti-thyroid treatment in patients with Graves' disease. |
2006 |
Horm. Res. |
pmid:16912510
|
Roudier MP et al. |
Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats. |
2006 |
Clin. Exp. Metastasis |
pmid:16912914
|
Kawasaki K et al. |
Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement. |
2006 |
Orthod Craniofac Res |
pmid:16918678
|
Menezes R et al. |
Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. |
2006 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:16920551
|
Neumann E |
[New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?]. |
2006 |
Z Rheumatol |
pmid:16924451
|
Rucci N et al. |
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio. |
2007 |
J. Cell. Biochem. |
pmid:16927271
|
Wang L et al. |
[Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action]. |
2006 |
Yao Xue Xue Bao |
pmid:16927832
|